Bolivia Medical Device Registration Number Printing Requirements: Manual Section 5.7.1 Compliance Guide
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Section 5.7.1 of the Manual para Registro Sanitario de Dispositivos Médicos requires that every medical device registration number be placed on the packaging in a clearly visible position using one of three accepted methods: direct printing, a stamp applied with indelible ink, or a label. All three methods are equally acceptable, which is a materially useful flexibility for small-volume products. A company does not need to commission a separately printed packaging run exclusively for Bolivia; a self-adhesive label or an indelible ink stamp applied after certification can satisfy the obligation. GRZAN notes that this duty does not stand alone. It is applied on the same packaging surface together with the Bolivian enterprise identification required under Article 149 of Decreto Supremo N° 25235 and the minimum label content required under Section 2.5 of the Manual, and all of these markings fall squarely within the scope of on-site inspections conducted by AGEMED and the Departmental Health Services, known as SEDES, across the nine departments of Bolivia. In practice, the registration number is the single most frequently checked marking during warehouse visits, because an inspector can verify it in seconds against the certificate. The interaction between the three marking layers also matters: the number, the local enterprise identification, and the minimum content items each occupy space on the same label, so the layout should be planned once, as a single exercise, rather than patched element by element as each obligation becomes due. Companies that plan the label as one integrated design avoid reprints caused by overlapping or obscured mandatory elements. Where multiple presentations or pack sizes exist under one certificate, the number must appear on each sales unit, so the artwork review should cover every SKU rather than a single representative pack.
2. Legal basis
| Regulation | Reference number | Publication date | Provision |
|---|---|---|---|
| Manual para Registro Sanitario de Dispositivos Médicos | Resolución Ministerial N° 010 | Current version as published on the AGEMED website | Section 5.7.1 |
| Manual para Registro Sanitario de Dispositivos Médicos | Resolución Ministerial N° 010 | Current version as published on the AGEMED website | Section 2.5 |
| Decreto Supremo (implementing regulation of the medicines law) | Decreto Supremo N° 25235 | 30 November 1998 | Article 149 |
| Decreto Supremo (establishing AGEMED) | Decreto Supremo N° 2905 | 21 September 2016 | Article 2 |
3. Expert insights
Insight one: the indelible ink stamp option is a rule designed with operational reality in mind. The drafters recognized the economics of small-batch imports: if direct printing were mandatory, low-volume products could not achieve compliance in a commercially viable way. Companies can use this flexibility to design a post-certification labeling workflow, applying the registration number by label or stamp only after the sanitary registration has been issued, rather than delaying packaging production until the certificate arrives. This shortens the path from certificate issuance to first shipment. It also preserves the commercial value of pre-printed generic packaging: outer cartons and inner packs can be produced in advance, and the Bolivia-specific element is added at the last responsible moment, once the registration number assigned by AGEMED is known.
Insight two: the clearly visible position is a qualitative requirement that must be read together with inspection practice. The Manual does not define the phrase clearly visible position. The GRZAN practical estimate is that the number should appear on the same face as the principal label and be identifiable without opening or unwrapping the pack. If the registration number is printed on a side panel, the bottom flap, or an inner surface that only becomes visible after unwrapping, it may be questioned during an inspection, even though the letter of the rule has technically been met.
Insight three: the printing obligation is linked to warehouse verification. Section 2.6 of the Manual allows AGEMED to visit importers and license holders at any time to verify products on site. If the physical stock observed during such a visit does not carry the registration number, that stock is itself evidence of non-compliance. This means the physical condition of goods already sitting in the importer warehouse must be brought up to the post-certification marking requirements in step with incoming shipments. Updating only in-transit consignments while leaving older stock unmarked is a common and avoidable failure mode. A practical sequence works well: when the sanitary registration certificate is issued, freeze new dispatches, schedule a labeling or stamping session for all warehouse stock, and record completion with dated photographs so that the importer can demonstrate compliance on the day of any unannounced visit. The same record supports the annual review obligations of the license holder and shortens the preparation time for AGEMED or SEDES inspections, because the physical evidence and the documentary evidence are already aligned.
4. Practical recommendations
- Reserve a dedicated area for the registration number in the label artwork at the design stage, so that a label or stamp of predictable size can be applied without obscuring any mandatory label element required under Section 2.5.
- Define the prominent position by the same-face standard: the number must sit on the same face as the principal label and be readable without unpacking. Avoid side panels, bottom flaps, and surfaces visible only after opening.
- Include the marking update of warehouse stock in the post-certification action list, and treat it as a gate before releasing any lot for sale. Reconcile warehouse stock against in-transit consignments at every receipt so that no unmarked unit remains on the shelf once the certificate is issued.
5. Verification checklist
- □ Has the registration number application method been fixed among printing, indelible ink stamp, or label?
- □ Is the number on the same face as the principal label and identifiable without unwrapping?
- □ Has the Bolivian enterprise identification required under Article 149 been applied at the same time?
- □ Has the marking of stock already held in the warehouse been synchronized with incoming goods?
- □ Can marked physical product be produced immediately during an on-site inspection?
Regulatory information verified as of October 29, 2026.
GRZAN supports medical device manufacturers, importers, and authorized representatives with sanitary registration, labeling, and post-market compliance in Bolivia. For assistance with this topic, contact info@grzanglobal.com.
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us